Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.8310
-0.1290 (-13.44%)
At close: May 9, 2025, 4:00 PM
0.8000
-0.0310 (-3.73%)
After-hours: May 9, 2025, 7:59 PM EDT
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $5.03 million as of May 9, 2025. Its market cap has decreased by -35.33% in one year.
Market Cap
5.03M
Enterprise Value
-1.89M
1-Year Change
-35.33%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $5.03M, a decrease of -92.30%. That is a compound annual growth rate of -50.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 5.81M | 45.64% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 669.79B |
| Johnson & Johnson | 371.76B |
| UnitedHealth Group | 344.35B |
| AbbVie | 330.75B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 232.77B |
| Novartis AG | 215.89B |
| AstraZeneca | 211.14B |